The Australian Competition Authority outlines preliminary competition concerns with a proposed merger between 2 animal health companies (Zoetis / Jurox)

Zoetis' proposed acquisition of Jurox raises preliminary competition concerns* The ACCC has outlined preliminary competition concerns with Zoetis’ proposed acquisition of Jurox in a statement of issues published today. Zoetis and Jurox develop, manufacture, and sell animal health products that detect, prevent, or treat health issues in companion and production animals. “We have concerns that the acquisition will remove one of Zoetis’ closest competitors in the supply of three types of products that are used by farmers to treat or prevent bacterial infections in the teats of cows,” ACCC Deputy Chair Mick Keogh said. “We also have

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Australian Competition Authority, The Australian Competition Authority outlines preliminary competition concerns with a proposed merger between 2 animal health companies (Zoetis / Jurox), 17 February 2022, e-Competitions February 2022, Art. N° 105208

Visites 379

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues